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PAO and whether perfusion contributes to new bone formation in the
acetabular fragment. The purpose of this study was to quantify blood
perfusion and bone formation before and after PAO analysed by Positron
Emission Tomography (PET) combined with Computed Tomography
(CT).
Methods: Twelve dysplastic patients (nine women) were included
consecutively in the study all operated by the senior author. Median
age was 33 (23–55) years. Initially, two patients were PET scanned in
a pilot study to test our models for calculation of the physiological
parameters. The following ten patients had their hip joints PET/CT
scanned immediately before PAO and 3–4 weeks after. Due to patients
moving on the scanner bed while scanning, data of sufﬁciently high
quality was only available for six out of ten. [O-15]-water was used
to quantify blood perfusion and [F-18]-ﬂuoride was used to produce
quantitative images interpreted as new bone formation in/around
the acetabular fragment. The perfusion [ml blood/min/ml bone] was
determined from a one-compartment model, with the parameters:
K1, k2 and the delay. The ﬂuoride-clearance per volume bone (Ki)
[ml blood/min/ml bone] was determined by applying Patlak graphical
analysis to the ﬂuoride scan, ﬁtting the data from 45 to 90 min.
Results: The blood perfusion on the operated acetabulum before surgery
was 0.07±0.02ml/min/ml, and after surgery 0.19±0.03ml/min/ml
(p < 0.00). Blood perfusion on the non-operated acetabulum was
0.07±0.02ml/min/ml before PAO and 0.07±0.02ml/min/ml after surgery
(p = 0.47).
The ﬂuoride-clearance per volume bone on the operated acetabulum was
0.02±0.01ml/min/ml preoperatively, and 0.06±0.01ml/min/ml postop-
eratively (p < 0.00). Fluoride-clearance on the non-operated acetabulum
was 0.01±0.01ml/min/ml before PAO and 0.02±0.01ml/min/ml after PAO
(p =0.49).
Conclusions: Blood perfusion and new bone formation increased
signiﬁcantly in the acetabular fragment demonstrating that blood
perfusion to the acetabular fragment is not critically compromised after
minimally invasive PAO a.m. Soballe. Three to four weeks after PAO, bone
formation in the acetabular fragment on the operated side had increased
signiﬁcantly. This is the ﬁrst paper applying PET/CT to quantify blood
perfusion and bone formation before and after PAO.
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SMOOTHENING OF PERIARTICULAR BONE: BLOCKADE OF THE
HEDGEHOG PATHWAY INHIBITS OSTEOPHYTE FORMATION IN
ARTHRITIS
G. Ruiz-Heiland1, A. Horn1, P. Zerr1, W. Hofstetter2, W. Baum1, M. Stock1,
J. Distler1, F. Nimmerjahn1, G. Schett1, J. Zwerina3. 1Univ. of Erlangen,
Erlangen, Germany; 2Univ. of Bern, Bern, Switzerland; 3Hanusch Hosp.,
Vienna, Austria
Purpose: Osteophyte formation is a common phenomenon in arthritis.
Bone formation by endochondral ossiﬁcation is considered a key
pathophysiologic process to form osteophytes. We hypothesized that
inhibition of Smoothened (Smo), a key component of the hedgehog
pathway inhibits osteophyte formation as the hedgehog pathway
mediates endochondral ossiﬁcation.
Methods: We induced arthritis in 8 weeks old C57/BL6 mice by serum
transfer (KxBN model). Mice were then treated by daily administration
of either vehicle or LDE 223, a speciﬁc small molecule inhibitor for Smo,
over 2 weeks starting at the onset of disease. Clinical course of arthritis,
histological and molecular changes of bone in the affected joints as well
as systemic bone changes were assessed.
Results: Serum transfer induced arthritis led to severe osteophyte
formation within 2 weeks of onset. Blockade of Smo inhibited hedgehog
signaling in vivo and also signiﬁcantly inhibited osteophyte formation,
whereas the clinical and histopathologic signs of arthritis were not
affected. Also, systemic bone mass did not change. Smo inhibitor
particularly blocked the formation of hypertrophic chondrocytes and
collagen type X expression.
Conclusions: Our data indicate that blockade of hedgehog signaling
by targeting Smo speciﬁcally inhibits osteophyte formation in arthritis
without affecting inﬂammation and without eliciting bone destruction
at the local and systemic level. Blockade of SMO may thus be considered
as a strategy to speciﬁcally inﬂuence the periosteal bone response in
arthritis associated with bone apposition.
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TNFa INDUCES SIRT1 CLEAVAGE IN HUMAN OSTEOARTHRITIC
CHONDROCYTES
M. Dvir-Ginzberg1, O. Gabay2, H. Oppenhiemer1, H. Meir1, V. Gagarina2,
E. Lee2, A. Haze1, L. Kandel3, M. Liebergall3. 1Hebrew Univ. of Jerusalem,
Jerusalem, Israel; 2NIAMS, Bethesda, MD, USA; 3Hadassah Mount Scopus
Hosp., Jerusalem, Israel
Purpose: Osteoarthritis (OA) is a common degenerative joint disease
of articular cartilage (AC) characterized by a disrupted homeostasis of
extracellular matrix (ECM) synthesis and breakdown. It is often thought
that mechanical wear and tear of AC elicits OA pathology. However,
increasing reports indicate that synovial inﬂammation occurs in OA,
resulting in augmented levels of proinﬂammatory cytokines (mainly
TNFa and IL-1b) within synovial ﬂuid. Given that the NAD-dependent
protein deacetylase SirT1 promotes cartilage-type ECM expression and
chondrocyte survival, we postulate its function is altered in chondrocytes
exposed to proinﬂammatory cytokines, as TNFa.
Methods: TNFa-treated and untreated human osteoarthritic chondro-
cytes were analyzed for cartilage-speciﬁc gene expression, SirT1 activity
and ChIP analyses at the collagen 2a1 enhancer site. Human chondrocytes
transfected with an N-terminal Flag-tag SirT1 expression vector, were
treated with or without TNFa and analyzed by immunoblot for the
presence of SirT1. Protein extracts were immunoprecipitated for SirT1
following TNFa-treatment and analyzed via mass-spectroscopy and
Edman sequencing. In-vitro analysis of SirT1 activity and cleavage
was assayed in the presence of active Cathepsin B.Confocal images of
SirT1 monitored its subcellular trafﬁcking following TNFa stimulation.
Co-immunoﬂuorescent staining and confocal visualization was carried
out for Cathepsin B, mitochondrial Cox IV and Lysosome-associated
membrane protein I (LAMP-I) together with SirT1. Human chondrocyte
were tested for apoptosis via FACS analysis for Annexin V and
immunoblotting for active caspase 3 and 8. TNFa treated mitochondrial
extracts were obtained and immunopreciptated to detect the presence
of cleaved-SirT1. Finally human osteoarthritic and normal samples were
analyzed for the presence of active Cathepsin B, MMP13 and cleaved-
SirT1.
Results: TNFa-treated chondrocytes had impaired SirT1 enzymatic
activity and displayed full-length SirT1 protein (110kDa, FL-SirT1)
and a smaller 75kDa SirT1 fragment (i.e 75kDa SirT1). 75kDa SirT1
was generated via Cathepsin B-mediated cleavage at residue 533,
following TNFa stimulation. Confocal images revealed that 75kDa SirT1
was exported to the cytoplasm and colocalized with mitochondrial
membrane protein Cox IV, following TNFa stimulation. Prohibiting
nuclear export of 75kDa SirT1 via Leptomycine B or reducing its
protein levels in the presence of TNFa, led to a 10-fold increase in
apoptotic chondrocytes. Finally, Cathepsin B, responsible for 75kDa
SirT1 generation, was found elevated in TNFa-treated and OA-derived
chondrocytes vs. untreated and normal chondrocytes, respectively. As an
additional proof of principle, we show that normal human chondrocytes
exposed to synovial ﬂuid derived from OA patients generate 75kDa SirT1
fragment.
Conclusion: These data indicate that TNFa, a cytokine that mediates
joint inﬂammation in OA, induces Cathepsin B-mediated cleavage of
SirT1, resulting in a cytoplasmic 75kDa SirT1 fragment with impaired
enzymatic activity. The impaired enzymatic activity of 75kDa SirT1
correlates with reduced cartilage-ECM gene expression evident in TNFa
treated chondrocytes. In parallel, our data show that the stable 75kDa
SirT1 fragment promotes chondrocyte survival when exposed to TNFa.
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THE ROLE OF THE PROGRESSIVE ANKYLOSIS PROTEIN (ANK) IN
OSTEOARTHRITIS
K. Campbell, S. Hadley, T. Minashima, T. Kirsch. NYU Sch. of Med., New
York, NY, USA
Purpose: Currently there are no treatments available for osteoarthritis
(OA). In order to establish new therapeutic strategies for the treatment of
OA, a better understanding of the cellular and molecular changes during
OA progression is required. The progressive ankylosis protein (ANK) is a
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transmembrane protein that transports intracellular pyrophosphate (PPi)
to the extracellular milieu. Previous studies have shown that extracellular
PPi and inorganic phosphate (Pi) resulting from PPi hydrolysis affect
cartilage mineralization as well as chondrocyte differentiation. In
addition, several lines of evidences suggest that ANK via its cytoplasmic
N-terminal and C-terminal domains interacts with other proteins and
these interactions may modulate signaling pathway activities. Since ANK
expression is low in normal healthy articular cartilage and its expression
levels increase in OA pathology, we investigated the role of ANK in OA
pathology.
Methods: Human articular chondrocytes isolated from left-over tissue
after knee replacement surgery were transfected with ank expression
vector and cultured in the absence or presence of interleukin-1 (IL-1) and
zoledronic acid, a bisphosphonate and non-hydrolysable PPi analogue.
mRNA levels of markers of articular chondrocytes (aggrecan, Sox-9. type
II collagen), hypertrophic markers (alkaline phosphatase (APase), runx2,
type X collagen), and MMP-13 were determined by real time PCR. NF-úB
activity was determined by transfection of human chondrocytes with
a NF-úB-speciﬁc luciferase reporter plasmid. Mineralization of human
chondrocytes in the absence or presence of PPi and levamisole (to prevent
PPi hydrolysis) was determined using alizarin red S staining. Finally,
femoral head explants isolated from ank/ank mice, which lack functional
ANK, and wild type littermates were cultured in the absence or presence
of IL-1.
Results: Overexpression of ANK in human chondrocytes resulted in
decreased mRNA levels of articular cartilage markers and increased
mRNA levels of hypertrophic markers and MMP-13. Treatment of
human chondrocytes with PPi and levamisole (to prevent hydrolysis
of PPi) resulted in decreased hypertrophic differentiation and MMP-
13 expression but propagation of mineral formation. Consequently,
zoledronic acid increased aggrecan mRNA levels and decreased
hypertrophic marker and MMP-13 mRNA levels in human chondrocyte
cultures in human chondrocytes cultured in the presence or absence
of IL-1. These ﬁndings reveal that increased extracellular Pi levels
as a consequence of extracellular PPi hydrolysis are the cause for
increased hypertrophic differentiation and MMP-13 expression in ANK
expressing articular chondrocytes, whereas increased extracellular PPi
concentrations lead to calcium pyrophosphate mineral formation. ANK
overexpression in human chondrocytes also resulted in increased
luciferase activity of a NF-úB-speciﬁc luciferase reporter. In the presence
of IL-1 the increase of NF-úb activity in ANK overexpressing human
chondrocytes was even more profound than in the absence of IL-1.
The stimulatory role of ANK on NF-úB activity was a consequence of
the interaction of ANK with MYBBP1a, which prevented the shuttling
of MYBBP1a into the nucleus, where it acts as an inhibitor of NF-úB.
Finally, treatment of ank/ank femoral head explants with IL-1 resulted in
a markedly reduced loss of proteoglycans and MMP-13 immunostaining
compared with IL-1-treated wild type explants.
Conclusion: ANK via its regulatory role of PPi/Pi homeostasis and
its interaction with MYBBP1a stimulates hypertrophic differentiation,
mineralization, NF-úB activity, and MMP-13 expression in chondrocytes
during OA pathology. Interfering with ANK-mediated transport of PPi
and/or its interaction with MYBBP1a may provide novel therapeutic
strategies for the treatment of OA.
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CYTOKINES DOWNREGULATE NPP1 AND THEREFORE INDUCE
CARTILAGE MINERALIZATION IN OA
J. Bertrand1, Y. Nitschke2, M. Fuerst3, W. Ruether4, F. Rutsch2, G. Nalesso1,
F. Dell’Accio1, T. Pap2. 1William Harvey Inst., London, United Kingdom;
2Univ. Hosp. Muenster, Muenster, Germany; 3MedBaltic, Neumuenster,
Germany; 4Univ. Hosp. Hamburg Eppendorf, HAmburg, Germany
Purpose: Calciﬁcation of cartilage is a common ﬁnding during
osteoarthritis (OA) and we have shown in a previous study that
it is directly linked to OA severity. The pyrophosphate pathway is
known to function in keeping the sensitive balance of pyrophosphate
and phosphate, thereby preventing the generation of calcium crystals.
One key player in this pathway is the nucleotide pyrophosphatase
phosphodiesterase (NPP1). In the present study we analysed the
expression of NPP1 in OA cartilage and its effects on changes in cartilage
biology.
Methods: We stimulated chondrocytes with IL-1 and TNFalpa and
analysed the expression of NPP1, using quantitative real time PCR
(qPCR). In 120 consecuitve OA patients, we isolate RNA and assessed the
expression of NPP1, ANK and TNAP by qPCR. We analysed the expression
of NPP1 in induced OA in C57/bl6 mice, as well as in cartilage samples of
OA patients by immunhistochemical stainings.The mouse that carrying
a mutation in the enpp1 gene, was used to measure the calciﬁcation
of cartilage by ﬂuorid PET-scanning and mCT. Using von Kossa in
combination with safranin orange stainings of knee sections, we assessed
the calciﬁcation of articular cartilage and menisci histologically and the
severitiy of OA using the Mankin Score of mouse and human samles.
To investigate cartilage remodelling we performed immunohistological
stainings for collagen I, collagen X, osteopontin and TRAP.
Results: Both tested cytokines downregulate the expression of NPP1.
The expression of NPP1, but not ANK and TNAP, inversely correlated
with cartilage calciﬁcation (p < 0.05) and also with the Mankin-Score.
Such inverse correlation was conﬁrmed in experimental murine OA
and was also seen on protein level. We showed that NPP1mut/mut
mice have more calciﬁcation activity than wild type controls in joints.
NPP1mut/mut mice developed typical OA-like changes as evaluated
by histological analysis as well as in vivo imaging and histological
stainings. Calciﬁcation was associated with increased expression of the
hypertrophic cartilage marker collagen X and the bone marker. We
detected osteoclasts at the interface between bone and cartilage.
Conclusions: We conclude, that NPP1 is an important player in
OA-associated cartilage calciﬁcation. Pathologic calciﬁcation in the
NPP1mut/mut mice leads to cartilage remodelling into bone.These data
suggest that OA is characterized by the re-activation of molecular
signalling cascades leading to cartilage ossiﬁcation and resemble
endochondral ossiﬁcation.
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GPR22 OVEREXPRESSION ALTERS THE COURSE OF CHONDROGENESIS
TOWARDS CHONDROCYTE HYPERTROPHY AND MATRIX
MINERALIZATION: A POSSIBLE LINK TO OSTEOARTHRITIS ?
F. Cailotto, R.J. Lories. Katholieke Univ.it Leuven, Leuven, Belgium
Purpose: Osteoarthritis (OA) is a highly disabling pathology of the bone-
cartilage unit, with origins being both patient-dependent (weight excess,
trauma . . . ) and genetic. Recently, a locus on Chromosome 7 (7q22) was
linked to knee and hand OA by genome wide association study. In this
locus, the GPR22 gene, which codes for an orphan G-coupled receptor,
is almost absent from healthy cartilage, but strongly upregulated
in OA cartilage. As some aspects of endochondral bone formation
are recapitulated in OA (loss of stable phenotype, hypertrophy), we
investigated the inﬂuence of GPR22 during chondrogenesis.
Methods: We used the ATDC5 chondrogenic cell line. Three independent
stable clonal colonies of each, control (empty vector) and GPR22
overexpressing cells (GPR22+), were selected over 21 days (D)
using geneticin. Clones were cultured as high density micromasses
(2×105 cells/10ml) to mimic the condensation step of developing
cartilage in vivo. Chondrogenesis was induced by culturing cells
for 14D in DMEM/F12 + 5% FBS, supplemented with ITS [insulin
(10mg/ml), transferrin (10mg/ml) and sodium selenite (3 x 10–8 M)].
On D14, cells were switched to mineralization medium (aMEM +
5% FBS, supplemented with ITS) to investigate the mineralization
phase of chondrogenesis. mRNA expression of typical chondrogenesis
markers (Aggrecan (Agg), type II (Col2a1) and X (Col10a1) collagens,
Indian hedgehod (Ihh), transcription factors Sox9 and Runx2, alkaline
phosphatase (Alp) and matrix metalloproteinase (Mmp)-13) were
assessed by quantitative RT-PCR. Quantiﬁcation of Alcian Blue, Sirius red
and Alizarin red staining were used to evaluate proteoglycans, collagens
and mineralized content respectively. ERK1/2 activation, shown to be
enhanced during mineralization, was evaluated by western blot. Cell
proliferation was checked using Neutral red staining, and cell viability
was checked with Live/Dead® cell assay.
Results: During proliferation (D1–7) and hypertrophy (D11–14), Col2a1
mRNA was strongly increased in controls, but not in GPR22+. Agg mRNA
and alcian blue were less upregulated in GPR22+ than in controls. Col10a1
mRNA was detectable on D11, and strongly increased at D14 in controls,
but was signiﬁcantly higher in GPR22+. Sirius red and neutral red
intensity increased over time, and were signiﬁcantly higher in controls.
However, no difference was detected for cell viability. Sox9 mRNA was
increased at D7 in controls, while it remained unchanged in GPR22+.
Ihh and Runx2 mRNA were increased signiﬁcantly at D11 in controls,
while they were at D7 in GPR22+. Alizarin red was negative in controls,
